Regeneron Pharmaceuticals Inc. / AMD Alliance International / Regulatory Affairs Regeneron Pharmaceuticals Inc. / AMD / Sponsor Presentation Regeneron Pharmaceuticals Inc. / Development Sciences Regeneron Pharmaceuticals Inc. / M.D. / /
Event
FDA Phase / /
Facility
Marriott Inn / University of Maryland University College / Cleveland Clinic Lerner College / /
IndustryTerm
aflibercept ophthalmic solution / /
MedicalCondition
neovascular age-related macular degeneration / /
Organization
American Health Assistance Foundation / office of New Drugs / Food and Drug Administration / Medicine Vitreoretinal Surgeon Cole Eye Institute / Harvard / Tufts University School of Medicine Clinical / FDA / Food and Drug Administration Center for Drug Evaluation / University of Maryland University College / Information Office / Center for Drug Evaluation and Research / office of Antimicrobial Products / Cleveland Clinic Lerner College of Medicine Vitreoretinal / Division of Transplant and Ophthalmology Products / Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Dermatologic / /
Person
Ronald P. Rapini / Pharmacology Neil Stahl / Ph.D. Sr. / Mary E. Maloney / Edward M. Cox / Michael Repka / Charles A. Rohde / Peter Zloty / DODAC FDA / Jean L. Bolognia / Lynn A. Drake / Allan R. Rutzen / Sancy A. Leachman / Wiley Chambers / Ellen R. Strahlman / Yvette Waples / Mary A. Majumder / Sonal Wadhwa / Marcia D. Carney / Guy S. Eakin / Donald Fong / Need Jeffrey Heier / Lynn K. Gordon / George Yancopoulos / Paul F. Lizzul / Efficacy Ned Braunstein / Laina King / Remarks Wiley Chambers / /
Position
Chief Scientific Officer / Professor of Ophthalmology / Federal Officer / Executive Director / Deputy Director / Director / Digital Coherence Tomography Reading Center / Founding Director / Cleveland Clinic / Sr. Vice President / physician / Medical Officer / Representative / Designated Federal Officer / Vitreoretinal Specialist / Cleveland Clinic Founding Director / Digital Coherence Tomography Reading Center / Chair Committee / /
Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Dermatologic and Ophthalmic Drugs Advisory Committee June 17, 2011